Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
暂无分享,去创建一个
David A. Lewis | D. Volk | J. Glausier | Allison A. Curley | Jill R. Glausier | David W. Volk | D. Lewis
[1] S. Akbarian,et al. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.
[2] P. Somogyi,et al. Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations , 2008, Science.
[3] Jong H. Yoon,et al. GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.
[4] Wei Zhang,et al. Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.
[5] T. Woo,et al. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. , 2004, Archives of general psychiatry.
[6] Burton S. Rosner,et al. Neuropharmacology , 1958, Nature.
[7] P. Somogyi,et al. Differential synaptic localization of two major y-aminobutyric acid type A receptor a subunits on hippocampal pyramidal cells , 1996 .
[8] Dennis Velakoulis,et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. , 2009, Archives of general psychiatry.
[9] Yogesh K. Dwivedi,et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Tamás,et al. Differential distribution of KCC2 along the axo‐somato‐dendritic axis of hippocampal principal cells , 2010, The European journal of neuroscience.
[11] Jim van Os,et al. The environment and schizophrenia , 2010, Nature.
[12] A. Sampson,et al. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. , 2002, Cerebral cortex.
[13] S. Floresco,et al. Reducing Prefrontal Gamma-Aminobutyric Acid Activity Induces Cognitive, Behavioral, and Dopaminergic Abnormalities That Resemble Schizophrenia , 2011, Biological Psychiatry.
[14] Ken Mackie,et al. Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.
[15] D. Lewis,et al. Neuroplasticity of Neocortical Circuits in Schizophrenia , 2008, Neuropsychopharmacology.
[16] B H Gähwiler,et al. Mechanism of mu‐opioid receptor‐mediated presynaptic inhibition in the rat hippocampus in vitro. , 1993, The Journal of physiology.
[17] C. Chavkin,et al. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation , 1991, Neuron.
[18] C. Carter,et al. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Yuste,et al. The Enigmatic Function of Chandelier Cells , 2010, Front. Neurosci..
[20] Dost Öngür,et al. Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia , 2010, Biological Psychiatry.
[21] M. Roesch,et al. More Is Less: A Disinhibited Prefrontal Cortex Impairs Cognitive Flexibility , 2010, The Journal of Neuroscience.
[22] D. Peckys,et al. Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. , 2001, Brain research bulletin.
[23] R. Pearce,et al. GABAA,slow: causes and consequences , 2011, Trends in Neurosciences.
[24] Anthony A Grace,et al. A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia , 2009, The Journal of Neuroscience.
[25] R. Olsen,et al. GABAA receptors: Subtypes provide diversity of function and pharmacology , 2009, Neuropharmacology.
[26] S. Nelson,et al. Homeostatic plasticity in the developing nervous system , 2004, Nature Reviews Neuroscience.
[27] M. Schäfer,et al. Homeostatic Scaling of Vesicular Glutamate and GABA Transporter Expression in Rat Neocortical Circuits , 2005, The Journal of Neuroscience.
[28] David A Lewis,et al. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.
[29] Mark E. Williams,et al. Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain , 2000, Journal of Chemical Neuroanatomy.
[30] Fiona E. N. LeBeau,et al. Recruitment of Parvalbumin-Positive Interneurons Determines Hippocampal Function and Associated Behavior , 2007, Neuron.
[31] D. Lewis,et al. Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.
[32] A. Sampson,et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. , 2011, The American journal of psychiatry.
[33] R. Straub,et al. Expression of GABA Signaling Molecules KCC2, NKCC1, and GAD1 in Cortical Development and Schizophrenia , 2011, The Journal of Neuroscience.
[34] R. Sweet,et al. Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. , 2011, Cerebral cortex.
[35] Erin Walker,et al. Cortical opioid markers in schizophrenia and across postnatal development. , 2012, Cerebral cortex.
[36] B. Moghaddam,et al. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.
[37] J. Pierri,et al. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. , 2001, The American journal of psychiatry.
[38] István Ulbert,et al. Supplementary material to : Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus , 2010 .
[39] D. Lewis,et al. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. , 2008, Schizophrenia bulletin.
[40] T. Yagi,et al. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Woo,et al. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Lewis,et al. Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia , 2010, Current psychiatry reports.
[43] C. Carter,et al. Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia , 2006, Proceedings of the National Academy of Sciences.
[44] Adriano B. L. Tort,et al. Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons , 2009, Proceedings of the National Academy of Sciences.
[45] C. Drake,et al. Mu opioid receptors are in discrete hippocampal interneuron subpopulations , 2002, Hippocampus.
[46] C. Lupica. Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] D. Lewis,et al. Parvalbumin‐immunoreactive axon terminals in macaque monkey and human prefrontal cortex: Laminar, regional, and target specificity of type I and type II synapses , 1999, The Journal of comparative neurology.
[48] C. Beasley,et al. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins , 2002, Biological Psychiatry.
[49] Sarah E. Forster,et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. , 2008, The American journal of psychiatry.
[50] P. Somogyi,et al. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Jonas,et al. Postnatal Differentiation of Basket Cells from Slow to Fast Signaling Devices , 2008, The Journal of Neuroscience.
[52] David A. Lewis,et al. Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits , 2010, Biological Psychiatry.
[53] Sze Py. L-Glutamate decarboxylase. , 1979 .
[54] Y. Goda,et al. Unraveling Mechanisms of Homeostatic Synaptic Plasticity , 2010, Neuron.
[55] A. Sampson,et al. Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits , 2004, Biological Psychiatry.
[56] T. Hashimoto,et al. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia , 2006, Molecular Psychiatry.
[57] John Suckling,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy , 2002 .
[58] Yogesh K. Dwivedi,et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.
[59] Michael F. Green,et al. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. , 2006, The Journal of clinical psychiatry.
[60] J. Glausier,et al. Selective Pyramidal Cell Reduction of GABAA Receptor α1 Subunit Messenger RNA Expression in Schizophrenia , 2011, Neuropsychopharmacology.
[61] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[62] K. Deisseroth,et al. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.
[63] S. Akbarian. MOLECULAR DETERMINANTS OF DYSREGULATED GABAERGIC GENE EXPRESSION IN THE PREFRONTAL CORTEX OF SUBJECTS WITH SCHIZOPHRENIA , 2010, Schizophrenia Research.
[64] P S Goldman-Rakic,et al. Synaptogenesis in the prefrontal cortex of rhesus monkeys. , 1994, Cerebral cortex.
[65] John Seibyl,et al. Probing GABA Receptor Function in Schizophrenia with Iomazenil , 2011, Neuropsychopharmacology.
[66] M. Webster,et al. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. , 2010, The American journal of psychiatry.
[67] Mark C. W. van Rossum,et al. Activity Deprivation Reduces Miniature IPSC Amplitude by Decreasing the Number of Postsynaptic GABAA Receptors Clustered at Neocortical Synapses , 2002, The Journal of Neuroscience.
[68] R. Yuste,et al. Dense, Unspecific Connectivity of Neocortical Parvalbumin-Positive Interneurons: A Canonical Microcircuit for Inhibition? , 2011, The Journal of Neuroscience.
[69] K. Mirnics,et al. Molecular markers distinguishing supragranular and infragranular layers in the human prefrontal cortex , 2007, The European journal of neuroscience.
[70] A. Arnsten. Stress signalling pathways that impair prefrontal cortex structure and function , 2009, Nature Reviews Neuroscience.
[71] David A Lewis,et al. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. , 2008, The American journal of psychiatry.
[72] S. Schulz,et al. Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. , 2004, The Journal of comparative neurology.
[73] M. Vreugdenhil,et al. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. , 2003, Journal of neurophysiology.
[74] B. Alger,et al. Synaptic Cross Talk between Perisomatic-Targeting Interneuron Classes Expressing Cholecystokinin and Parvalbumin in Hippocampus , 2009, The Journal of Neuroscience.
[75] J. Pierri,et al. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. , 1999, The American journal of psychiatry.
[76] Jon W. Johnson,et al. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. , 2009, The American journal of psychiatry.
[77] Cameron S Carter,et al. Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode Schizophrenia , 2010, Neuropsychopharmacology.
[78] M. Minzenberg,et al. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. , 2009, Archives of general psychiatry.
[79] R. Yoshimura,et al. Associations between plasma levels of 3‐methoxy‐4‐hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early‐stage schizophrenia , 2009, Human psychopharmacology.
[80] Douglas L Rothman,et al. Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD67 protein , 2001, Brain Research.
[81] Jessica A. Cardin,et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses , 2009, Nature.
[82] Mark Farrant,et al. The cellular, molecular and ionic basis of GABA(A) receptor signalling. , 2007, Progress in brain research.
[83] R. Cho,et al. Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects , 2009, Neuropsychopharmacology.
[84] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.
[85] P. Tooney,et al. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[86] T. Woo,et al. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. , 1997, The American journal of psychiatry.
[87] Michael F. Green,et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. , 2011, The American journal of psychiatry.
[88] T. Kaneko,et al. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia , 2009, BMC psychiatry.
[89] E. Miller,et al. An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.
[90] R. Yoshimura,et al. Reduction of brain γ-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study , 2009, Schizophrenia Research.
[91] T. Hashimoto,et al. Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. , 2011, Cerebral cortex.
[92] D. Lewis,et al. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.
[93] David A Lewis,et al. Glutamate Receptor Subtypes Mediating Synaptic Activation of Prefrontal Cortex Neurons: Relevance for Schizophrenia , 2011, The Journal of Neuroscience.
[94] Peter Wenner,et al. Sensing and expressing homeostatic synaptic plasticity , 2007, Trends in Neurosciences.
[95] S. Schulz,et al. Neuronal types expressing μ‐ and δ‐opioid receptor mRNA in the rat hippocampal formation , 2004 .
[96] Richie Poulton,et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. , 2010, The American journal of psychiatry.
[97] R. Desimone,et al. Laminar differences in gamma and alpha coherence in the ventral stream , 2011, Proceedings of the National Academy of Sciences.
[98] S. Lawrie,et al. Longitudinal Volume Reductions in People at High Genetic Risk of Schizophrenia as They Develop Psychosis , 2011, Biological Psychiatry.
[99] T. Yagi,et al. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. , 1996, Biochemical and biophysical research communications.
[100] M. Webster,et al. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. , 2009, Journal of psychiatric research.
[101] B. Alger,et al. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others , 2008, Neuropharmacology.
[102] M. Huntsman,et al. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. , 1994, Cerebral cortex.
[103] I. Soltesz,et al. Cell type–specific gating of perisomatic inhibition by cholecystokinin , 2007, Nature Neuroscience.
[104] Norbert Hájos,et al. Network mechanisms of gamma oscillations in the CA3 region of the hippocampus , 2009, Neural Networks.
[105] Cameron S Carter,et al. Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning , 2011, Neuropsychopharmacology.
[106] G. Tamás,et al. Excitatory Effect of GABAergic Axo-Axonic Cells in Cortical Microcircuits , 2006, Science.
[107] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[108] M. Webster,et al. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. , 2010, Journal of psychiatric research.
[109] W. Carlezon,et al. Schizophrenia-Like Attentional Deficits Following Blockade of Prefrontal Cortex GABAA Receptors , 2011, Neuropsychopharmacology.
[110] T. Sawaguchi,et al. Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys , 2004, Experimental Brain Research.
[111] Lindsey L. Glickfeld,et al. Complementary Modulation of Somatic Inhibition by Opioids and Cannabinoids , 2008, The Journal of Neuroscience.
[112] F. Benes,et al. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects , 1996, Neuroscience.
[113] W. Fenton,et al. How should DSM-V criteria for schizophrenia include cognitive impairment? , 2007, Schizophrenia bulletin.
[114] D. Arion,et al. Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. , 2011, Archives of general psychiatry.
[115] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[116] Takanori Hashimoto,et al. Protracted Developmental Trajectories of GABA A Receptor α1 and α2 Subunit Expression in Primate Prefrontal Cortex , 2009, Biological Psychiatry.
[117] G. Knott,et al. GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual Cortex , 2007, Neuron.
[118] Goldman-Rakic. Cellular Basis of Working Memory Review , 2022 .
[119] Marc W Howard,et al. Gamma oscillations correlate with working memory load in humans. , 2003, Cerebral cortex.
[120] Lief E. Fenno,et al. Neocortical excitation/inhibition balance in information processing and social dysfunction , 2011, Nature.
[121] S. Eggan,et al. Postnatal development of pre‐ and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex , 2003, The Journal of comparative neurology.
[122] A. Sampson,et al. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.
[123] Xiao-Jing Wang. Neurophysiological and computational principles of cortical rhythms in cognition. , 2010, Physiological reviews.